TY - JOUR
T1 - Autonomous climbing
T2 - An effective exercise mode with beneficial outcomes of aerobic exercise and resistance training
AU - Shen, Fei
AU - Zhao, Yu
AU - Ding, Wubin
AU - Liu, Kailin
AU - Ren, Xiangyu
AU - Zhang, Qiang
AU - Yu, Jian
AU - Hu, Yepeng
AU - Zuo, Hui
AU - Guo, Mingwei
AU - Jin, Ling
AU - Gong, Mingkai
AU - Wu, Wenhao
AU - Gu, Xuejiang
AU - Xu, Lingyan
AU - Yang, Fenglei
AU - Lu, Jian
N1 - Publisher Copyright:
© 2020
PY - 2021/1/15
Y1 - 2021/1/15
N2 - Aims: To assess the effects of three specific exercise training modes, aerobic exercise (A), resistance training (R) and autonomous climbing (AC), aimed at proposing a cross-training method, on improving the physical, molecular and metabolic characteristics of mice without many side effects. Materials and methods: Seven-week-old male mice were randomly divided into four groups: control (C), aerobic exercise (A), resistance training (R), and autonomous climbing (AC) groups. Physical changes in mice were tracked and analysed to explore the similarities and differences of these three exercise modes. Histochemistry, quantitative real-time PCR (RT-PCR), western blot (WB) and metabolomics analysis were performed to identify the underlying relationships among the three training modes. Key findings: Mice in the AC group showed better body weight control, glucose and energy homeostasis. Molecular markers of myogenesis, hypertrophy, antidegradation and mitochondrial function were highly expressed in the muscle of mice after autonomous climbing. The serum metabolomics landscape and enriched pathway comparison indicated that the aerobic oxidation pathway (pentose phosphate pathway, galactose metabolism and fatty acid degradation) and amino acid metabolism pathway (tyrosine, arginine and proline metabolism) were significantly enriched in group AC, suggesting an increased muscle mitochondrial function and protein balance ability of mice after autonomous climbing. Significance: We propose a new exercise mode, autonomous climbing, as a convenient but effective training method that combines the beneficial effects of aerobic exercise and resistance training.
AB - Aims: To assess the effects of three specific exercise training modes, aerobic exercise (A), resistance training (R) and autonomous climbing (AC), aimed at proposing a cross-training method, on improving the physical, molecular and metabolic characteristics of mice without many side effects. Materials and methods: Seven-week-old male mice were randomly divided into four groups: control (C), aerobic exercise (A), resistance training (R), and autonomous climbing (AC) groups. Physical changes in mice were tracked and analysed to explore the similarities and differences of these three exercise modes. Histochemistry, quantitative real-time PCR (RT-PCR), western blot (WB) and metabolomics analysis were performed to identify the underlying relationships among the three training modes. Key findings: Mice in the AC group showed better body weight control, glucose and energy homeostasis. Molecular markers of myogenesis, hypertrophy, antidegradation and mitochondrial function were highly expressed in the muscle of mice after autonomous climbing. The serum metabolomics landscape and enriched pathway comparison indicated that the aerobic oxidation pathway (pentose phosphate pathway, galactose metabolism and fatty acid degradation) and amino acid metabolism pathway (tyrosine, arginine and proline metabolism) were significantly enriched in group AC, suggesting an increased muscle mitochondrial function and protein balance ability of mice after autonomous climbing. Significance: We propose a new exercise mode, autonomous climbing, as a convenient but effective training method that combines the beneficial effects of aerobic exercise and resistance training.
KW - Aerobic exercise
KW - Autonomous climbing
KW - Enriched pathway
KW - Metabolic
KW - Physiological adaptation
KW - Resistance training
UR - https://www.scopus.com/pages/publications/85096543747
U2 - 10.1016/j.lfs.2020.118786
DO - 10.1016/j.lfs.2020.118786
M3 - 文章
C2 - 33221346
AN - SCOPUS:85096543747
SN - 0024-3205
VL - 265
JO - Life Sciences
JF - Life Sciences
M1 - 118786
ER -